-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
Vistagen Therapeutics, Inc. quarterly/annual Depreciation, Depletion and Amortization history and growth rate from 2014 to 2023.
- Vistagen Therapeutics, Inc. Depreciation, Depletion and Amortization for the quarter ending June 30, 2024 was $34K, a 6.25% increase year-over-year.
- Vistagen Therapeutics, Inc. annual Depreciation, Depletion and Amortization for 2023 was $127K, a 2.31% decline from 2022.
- Vistagen Therapeutics, Inc. annual Depreciation, Depletion and Amortization for 2022 was $130K.
- Vistagen Therapeutics, Inc. annual Depreciation, Depletion and Amortization for 2020 was $118K, a 14.1% increase from 2019.
Depreciation, Depletion and Amortization, Trailing 12 Months (USD)
Depreciation, Depletion and Amortization, Annual (USD)
Depreciation, Depletion and Amortization, YoY Annual Growth (%)